← SynDRA
THEAFLAVIN
SynDRA canonical compound SYN0005290 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CYP19A1 | FASN | LIPC | LIPE | LIPG |
|---|
| Mechanism of action | antiviral |
|---|
All known targets
- CYP19A1
- FASN
- LIPC
- LIPE
- LIPG
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- BCL2
- CDK2
- CYP17A1
- SLCO1B1
- SLCO1B3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Antioxidants
- Chelating Agents
- antiviral
Cross-references
Synonyms
- C29H24O12
- Theaflavin (Standard)
- UNII-1IA46M0D13
- orb1299669
- orb3139540
- GTPL12464
- HY-N0243R
- HY-N0243
- BDBM50487716
- CS-5885
- AC-34090
- PD132145
- T7602
- Theaflavine
- (-)-Theaflavin
- CHEBI:136609
- 1IA46M0D13
- Theaflavins
- RefChem:932909
- DTXCID80119407
- MFCD03427500
- Spectrum_000527
- SpecPlus_000296
- THEAFLAVINE [MI]
- Spectrum2_001765
- Spectrum3_000698
- Spectrum4_001488
- Spectrum5_000195
- SCHEMBL19551
- SCHEMBL19552
- BSPBio_002455
- KBioGR_002095
- KBioSS_001007
- SPECTRUM200111
- DivK1c_006392
- SPBio_001629
- Theaflavin, analytical standard
- SCHEMBL29779739
Look up THEAFLAVIN in the interactive SynDRA portal →